Patents by Inventor Anthony M. Moody

Anthony M. Moody has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS AND METHODS FOR PREVENTING OR AMELIORATING NEONATAL HSV INFECTION
    Publication number: 20210340223
    Abstract: The present disclosure relates to compositions and methods for treating or preventing neonatal herpes simplex virus (HSV) infection and/or the neurological and/or non-neurological sequelae thereof.
    Type: Application
    Filed: October 10, 2019
    Publication date: November 4, 2021
    Inventors: Margaret E. Ackerman, Iara M. Backes, David A. Leib, Chaya D. Patel, Anthony M. Moody
  • Anti-Complement factor H antibodies
    Patent number: 10183988
    Abstract: Disclosed herein are Complement factor H (CFH) inhibitors, such as anti-CFH antibodies and small molecules, and methods of using said inhibitors.
    Type: Grant
    Filed: June 7, 2014
    Date of Patent: January 22, 2019
    Assignee: Duke University
    Inventors: Edward F. Patz, Jr., Michael J. Campa, Elizabeth Gottlin, Barton F. Haynes, Hua-Xin Liao, Anthony M. Moody
  • INHIBITORS OF COMPLEMENT FACTOR H
    Publication number: 20160311893
    Abstract: Disclosed herein are Complement factor H (CFH) inhibitors, such as anti-CFH antibodies and small molecules, and methods of using said inhibitors.
    Type: Application
    Filed: June 7, 2014
    Publication date: October 27, 2016
    Inventors: Edward F. Patz, JR., Michael J. Campa, Elizabeth Gottlin, Barton F. Haynes, Hua-Xin Liao, Anthony M. Moody
  • VACCINE FORMULATION
    Publication number: 20150359874
    Abstract: The present invention relates, in general, to a method of inducing an immune response to HIV-1 in a mammal and, in particular, to a vaccine formulation suitable for use in such a method comprising an HIV-1 envelope (Env) immunogen comprising recombinant Envs with some degree of high-mannose glycan residues and a Toll-like receptor (TLR) agonist-supplemented squalene-based adjuvant.
    Type: Application
    Filed: March 5, 2013
    Publication date: December 17, 2015
    Inventors: Anthony M. Moody, Barton F. Haynes
  • ADJUVANT
    Publication number: 20130243850
    Abstract: The present invention relates, in general, to human immunodeficiency vims (HIV-1) and, in particular, to a method of enhancing an immune response to an HIV-1 immunogen, and to compounds and compositions suitable for use in such a method.
    Type: Application
    Filed: November 23, 2011
    Publication date: September 19, 2013
    Applicant: DUKE UNIVERSITY
    Inventors: Barton F. Haynes, Laurent Verkoczy, Anthony M. Moody, Matt T. Holl, Masayuki Kuraoka, Garnett Kelsoe